Companies sponsors |
TauRx Therapeutics (hydromethylthionine mesylate) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Alzheimer’s Research UK |
|
Alzheimer's Society |
|
Dementia UK |
Professional groups |
Association of British Neurologists |
|
College of Mental Health Pharmacy |
|
Royal College of Physicians |
|
Royal College of Psychiatrists |
Associated public health groups |
None |
Comparator companies |
Eisai (donepezil, lecanemab) (confidentiality agreement signed, participating) |
|
Eli Lilly and Company (donanemab) (confidentiality agreement signed, participating) |
|
Novartis Pharmaceuticals (rivastigmine) (confidentiality agreement signed, participating) |
|
Accord-UK (donepezil, galantamine, memantine) (confidentiality agreement not signed, not participating) |
|
Aspire Pharma (galantamine) (confidentiality agreement not signed, not participating) |
|
Aurobindo Pharma – Milpharm (donepezil, galantamine) (confidentiality agreement not signed, not participating) |
|
Cipla (donepezil) (confidentiality agreement not signed, not participating) |
|
Dr Reddy’s Laboratories (galantamine, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
|
Fontus Health (galantamine) (confidentiality agreement not signed, not participating) |
|
Genus Pharmaceuticals (memantine) (confidentiality agreement not signed, not participating) |
|
Glenmark Pharmaceuticals (memantine) (confidentiality agreement not signed, not participating) |
|
Kent Pharma (rivastigmine) (confidentiality agreement not signed, not participating) |
|
Krka UK (memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
|
Lundbeck (memantine) (confidentiality agreement not signed, not participating) |
|
Lupin Healthcare (memantine) (confidentiality agreement not signed, not participating) |
|
Mylan (donepezil, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
|
Ranbaxy, a Sun Pharmaceutical Company (donepezil) (confidentiality agreement not signed, not participating) |
|
Rosemont Pharmaceuticals (donepezil, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
|
Sandoz (galantamine, rivastigmine) (confidentiality agreement not signed, not participating) |
|
Takeda (galantamine) (confidentiality agreement not signed, not participating) |
|
Thame Laboratories (galantamine) (confidentiality agreement not signed, not participating) |
|
Zentiva (memantine, galantamine) (confidentiality agreement not signed, not participating) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
National Hospital for Neurology and Neurosurgery |